Skip to main content

The BIOFIRE® SPOTFIRE® Respiratory/Sore Throat Solution

Multiplex PCR Testing Built for the Point of Care

An evolving world deserves evolved diagnostics. As the leader in syndromic PCR testing, bioMérieux has evolved our point-of-care respiratory testing solution by developing new products that put clinicians and patients front and center. bioMérieux is pleased to announce a revolutionary portfolio of versatile respiratory PCR tests that give clinicians options as they care for a variety of patients.

Product Overview

The BIOFIRE® SPOTFIRE® System

The SPOTFIRE System is the latest advancement in molecular infectious disease diagnostics. It is designed to run the SPOTFIRE Respiratory/Sore Throat Panels.

  • Requires minimal benchtop space and can be scaled vertically, up to four modules, enabling customizable throughput
  • Easy to use with an intuitive system interface and streamlined workflow
  • Can be used by any healthcare professional in any healthcare setting
  • Seamlessly connects with point-of-care data management systems and other compatible systems and software
female-tech-using-torch-instrument

1. Calculation based on running the BIOFIRE® SPOTFIRE® R PANEL (~15 minutes) in an 8 hour shift.

BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel

1 PCR Test. Up to 15 Targets. ~15 Minutes.

The SPOTFIRE R/ST Panel enables testing for both respiratory or sore throat pathogens on the same panel, providing a flexible respiratory solution to meet the unique needs of your care setting.  FDA CLEARED | CLIA WAIVED

female-tech-using-torch-instrument
Sample Type: Nasopharyngeal or throat swab in transport media 
Hands-on time: 1-2 minutes
Overall Respiratory Performance (NPS specimens): PPA: 98.5% NPA: 99.1%
Overall Sore Throat Performance (TS specimens): PPA: 95.9% NPA: 99.0%
SPOTFIRE R/ST PANEL MENU
RESPIRATORY SORE THROAT
VIRUSES: VIRUSES:
 
 
 
  • Adenovirus
  • Coronavirus SARS-CoV-2
  • Coronavirus (seasonal)
  • Human metapneumovirus
  • Human rhinovirus/enterovirus
  • Influenza A virus
    • Influenza A virus A/H1-2009
    • Influenza A virus A/H3
  • Influenza B virus
  • Parainfluenza virus
  • Respiratory syncytial virus
 
  • Adenovirus
  • Coronavirus (seasonal)
  • Human metapneumovirus
  • Human rhinovirus/enterovirus
  • Influenza A virus
    • Influenza A virus A/H1-2009
    • Influenza A virus A/H3
  • Influenza B virus
  • Parainfluenza virus
  • Respiratory syncytial virus
BACTERIA: BACTERIA:
  • Bordetella parapertussis
  • Bordetella pertussis
  • Chlamydia pneumoniae
  • Mycoplasma pneumoniae
 
  • Chlamydia pneumoniae
  • Mycoplasma pneumoniae
  • Streptococcus dysgalactiae (group C/G strep)
  • Streptococcus pyogenes (group A strep)

BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini

1 PCR Test. 5 Targets. ~15 Minutes.

The SPOTFIRE R/ST Panel Mini tests for the 5 most probable viruses or bacteria that cause respiratory and sore throat symptoms, including influenza, rhinovirus, respiratory syncytial virus, SARS-CoV-2, and Streptococcus pyogenes
FDA CLEARED | CLIA WAIVED

female-tech-using-torch-instrument

Panel Specifications

Sample Type:
 Nasopharyngeal or throat swab in transport media 
Hands-on time: 1-2 minutes
Overall Respiratory Performance (NPS specimens):PPA: 98.7% | NPA: 98.4%
Overall Sore Throat Performance (TS specimens):PPA: 96.2% | NPA: 97.9%
SPOTFIRE R/ST PANEL MINI MENU
RESPIRATORYSORE THROAT
VIRUSES:VIRUSES:
 
 
  • Coronavirus SARS-CoV-2
  • Human rhinovirus
  • Influenza A virus
  • Influenza B virus
  • Respiratory syncytial virus
  • Human rhinovirus
  • Influenza A virus
  • Influenza B virus
  • Respiratory syncytial virus
 BACTERIA:
 
  • Streptococcus pyogenes (group A strep)

Rethink the Power of Diagnostics with the SPOTFIRE Respiratory/Sore Throat Solution to Potentially:

Inform Clinical Decisions

  • High sensitivity, specificity, and reliability provides results clinicians can trust
  • Contrary to tests that only detect the flu, SARS-COV-2, and/or RSV, a syndromic panel provides a fuller picture that may help inform patient management decisions

Optimize Operations

  • The simplified workflow and quick turnaround time enable rapid and accurate answers during the patient visit, while reducing the need for callbacks or expensive and slow send-out testing
  • This easy-to-use solution enables users of all skill levels to prepare and run samples

Optimize Antimicrobial Stewardship

  • Receiving comprehensive results in a clinically actionable timeframe may inform diagnoses while optimizing care and antimicrobial stewardship

Improve Patient Satisfaction

  • Using the right test, the first time to detect multiple pathogens may result in reduced follow-up appointments, swabbing, and testing, which could improve patient comfort, experience, and convenience
lab-techs-using-torch-instrument

Product availability varies by country. Consult your bioMérieux representative. 

Reference:

  1. Calculation based on running the BIOFIRE® SPOTFIRE® R PANEL (~15 minutes) in an 8 hour shift.
  2.  Overall performance and SARS-CoV-2 performance based on the prospective clinical study for the BIOFIRE SPOTFIRE Respiratory Panel.